Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2001;60:869-875
Copyright © 2001 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2001;60:869-875 ( September )

Extended report

Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial J Hill, H Bird, S Johnson

Clinical Pharmacology Unit (Rheumatism Research, University of Leeds), Chapel Allerton Hospital, Chapeltown Road, Leeds, West Yorkshire LS7 4SA, UK

Correspondence to: Dr J Hill howbird{at}ulth.northy.nhs.uk

Accepted for publication 23 January 2001

OBJECTIVE---To determine whether a patient education programme (PE) would improve rates of adherence to a slow acting antirheumatic drug and to assess any subsequent effect on patient outcome.
METHODS---A randomly controlled study comprising 100 patients with rheumatoid arthritis (49 control CG; 51 experimental EG) requiring D-penicillamine (DPA). The same practitioner saw patients on seven occasions, for the same length of time. The EG received 7 × 30 minute one to one sessions of PE, while the CG received standard management. The primary measure of adherence was a pharmacological marker (phenobarbitone) encapsulated with the DPA assayed at monthly intervals for six months. Plasma viscosity (PV), C reactive protein, articular index, morning stiffness, and pain score were used to assess outcome.
RESULTS---454 blood samples were collected and assayed and the pharmacological marker showed the EG to be significantly more adherent on more occasions than the CG (p<0.05). Patterns of adherence over time showed that at 12 weeks 86% (38/44) of those in the EG compared with 64% (29/45) of the CG remained adherent (p=0.01). These trends continued and by the end of the study 85% (29/34) of the EG compared with 55% (23/42) of the CG were taking their DPA as prescribed. Fifteen patients (12 from the EG) experienced side effects requiring study withdrawal and 14 patients requested study withdrawal (two from the EG). On study entry patients in the CG had significantly higher levels of PV than the EG and this remained so throughout the research. However, on completion, the health status of patients in both groups had improved significantly (p<0.01).
CONCLUSIONS---PE significantly increased adherence to DPA and its effects persisted over a period of six months. No additional clinical benefit was detected in the EG in comparison with the CG.


© 2001 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Berzins, K., Reilly, S., Abell, J., Hughes, J., Challis, D. (2009). UK self-care support initiatives for older patients with long-term conditions: a review. Chronic Illness 5: 56-72 [Abstract]  
  • Chambers, S. A., Rahman, A., Isenberg, D. A. (2007). Treatment adherence and clinical outcome in systemic lupus erythematosus. Rheumatology (Oxford) 46: 895-898 [Full Text]  
  • Kripalani, S., Yao, X., Haynes, R. B. (2007). Interventions to Enhance Medication Adherence in Chronic Medical Conditions: A Systematic Review. Arch Intern Med 167: 540-549 [Abstract] [Full Text]  
  • Treharne, G. J., Lyons, A. C., Hale, E. D., Douglas, K. M. J., Kitas, G. D. (2006). 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?. Rheumatology (Oxford) 45: 1-5 [Full Text]  
  • Neame, R., Hammond, A. (2005). Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford) 44: 762-767 [Abstract] [Full Text]  
  • Kurrle, S. E., Cameron, I. D., Quine, S. (2004). Predictors of Adherence With the Recommended Use of Hip Protectors. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59: M958-M961 [Abstract] [Full Text]  
  • Goodacre, L. J., Goodacre, J. A. (2004). Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology (Oxford) 43: 583-586 [Abstract] [Full Text]  
  • Hill, J., Bird, H. (2003). The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis. Rheumatology (Oxford) 42: 66-70 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs